Search results
Author(s):
Syed Yaseen Naqvi
,
Ibrahim G Salama
,
Ayhan Yoruk
,
et al
Added:
3 years ago
Heart failure is a progressive and fatal disease that affects more than 23 million people worldwide, and will affect more than 8 million people in the USA by 2030.1,2 Despite major advancements in medical and device treatments for heart failure in recent decades, the incidence of heart failure continues to rise. This epidemic has a major impact on patient quality of life, while imposing heavy…
View more
Author(s):
Marco Metra
,
Elisabetta Dinatolo
,
Nicolò Dasseni
Added:
3 years ago
Despite improvements in treatment, heart failure (HF) continues to have a progressive clinical course characterised by worsening of cardiac function and clinical condition, leading to a stage of advanced chronic HF. At this stage, the clinical picture is characterised by severe symptoms, frequent episodes of decompensation, poor quality of life and poor survival. Evidence-based medical treatments…
View more
Author(s):
Tonje Thorvaldsen
,
Lars H Lund
Added:
3 years ago
Heart failure (HF) is associated with poor quality of life, high risk of death and is the leading cause of hospitalisation.1 With an ageing population and improved care for cardiovascular diseases, the prevalence of HF is increasing. Despite advances in HF therapies, 1–10% of the population with HF progress to an advanced stage of the disease.2,3 In the US, an estimated 250,000–300,000 patients…
View more
Author(s):
Tania Deis
,
Kasper Rossing
,
Finn Gustafsson
Added:
1 year ago
Levosimendan in AHF and AdHF
Author(s):
Piergiuseppe Agostoni
,
Dimitrios T Farmakis
,
Jose M García-Pinilla
,
et al
Added:
3 years ago
Article
Author(s):
Anupam A Kumar
,
Lena E Tran
,
Aniket S Rali
,
et al
Added:
1 year ago
Feras Bader
Research Area(s) / Expertise:
Author
Garrick C Stewart
Research Area(s) / Expertise:
Author
Mandeep Mehra
Author
Aniket S Rali
Research Area(s) / Expertise:
Author